baber/WOPTO huggingface dataset:
Patent CA-2832307-A1 (CA)
Inventor: DUBENSKY THOMAS W
IPC: A61K39/00
Filed: 2012-04-06
Abstract: Compositions and methods are provided herein for improved dual immunization strategies that induce in a subject an immune response that includes a humoral immune response and cellular immune response, both CD4 and CD8 T lymphocyte immune responses, thereby providing a complete adaptive immune response to one or more antigens. The methods described are therefore useful for treating and/or preventing (i.e., reducing the likelihood or risk of occurrence) different diseases, disorders, and conditions such as cancers and infectious diseases for which induction of both a humoral immune response and cellular immune response is desired and beneficial.
Patent CA-2833004-A1 (CA)
Title: Flexible wick
Inventor: RAMIREZ JOHN
IPC: C11C5/00
Filed: 2012-04-18
Abstract: A candle wick includes a first layer of paper or dried pulp and a second layer of material selected from the group consisting of paper, silk, thread, textiles, corn fiberfill, cotton batting, bamboo fiber, soybean protein fiber, wood, alpaca hair, dried pulp, rosin, resin, and fibrous material. The first layer is attached to the second layer to form a candle wick that is pliable and shapeable from a generally flat shape to a generally curved shaped. When ignited, the material comprising the candle wick is capable of providing sufficient fuel to a flame to provide a substantially consistent burn from an upper portion to a lower portion. A wick clip includes a slot similarly sized and shaped to receive an undersurface of the pliable, shaped configuration of the candle wick. The candle wick and wick clip form a clip assembly. A candle comprises a pliable, shaped candle wick held in place by a similarly shaped wick clip.
Patent CA-2833834-A1 (CA)
Inventor: KAKIVAYA GOPALA KRISHNA
IPC: H04L12/24
Filed: 2005-08-29
Abstract: The present invention extends to methods, systems, and computer program products for organizing resources into collections to facilitate more efficient and reliable resource access. Namespace managers communicate with one another to form a federation namespace infrastructure. The infrastructure can efficiently route, migrate, and process namespace requests, such as, for example, namespace registration requests from providers requesting to manage portions of namespaces and lookup requests from consumers requesting access to managed resources. Resources can be registered in and made accessible from multiple different namespaces. Resources can be identified using nested queries that filter results at multiple levels of a hierarchical namespace.
Patent CA-2835285-A1 (CA)
Title: Therapeutic fusion proteins
Inventor: CHADDOCK JOHN
IPC: A61K47/48
Filed: 2012-05-16
Abstract: The present invention relates to the construction of a new class of Targeted Secretion Inhibitors (TSIs), which comprise a non-cytotoxic protease, translocation peptide and a targeting moiety peptide, wherein the targeting moiety peptide has a free N-terminal domain and a free C-terminal domain; to a single-chain fusion protein precursor thereof, and to a method of activating said single-chain fusion protein precursor.
Patent CA-2837009-A1 (CA)
Inventor: LEE DONGCHUL
IPC: A61N1/36
Filed: 2012-05-17
Abstract: A system for use with a neurostimulator coupled to one or more electrodes implanted adjacent neural tissue of a patient. The system comprises a user input device configured for allowing a user to select different nerve fiber diameters and to select a set of stimulation parameters. The system further comprises processing circuitry configured estimating regions of activation within the neural tissue of the patient based on the selected nerve fiber diameters and the selected stimulation parameter set. The system further comprises a display device configured for displaying the estimated regions of tissue activation. The user input device may further be configured for allowing the user to select different tissue regions of therapy, in which case, the display device may display the different tissue region on a human body map, and different indicia associating the displayed tissue regions for therapy to displayed estimated regions of tissue activation.
Patent CA-2838167-A1 (CA)
Title: System for closing a device for the low-pressure dispensing of a pasty liquid material
Inventor: DOULIN GWENAEL
IPC: B05B11/00
Filed: 2012-05-25
Abstract: The invention relates to a device (1) for dispensing a pasty liquid material (2) by means of a low-pressure manual metering pump (5), which is provided with an system for closing an end (32), and which is intended for a rigid or flexible container (4), the operation of said pump being ensured by: a lower check valve (11) and a metering chamber (10) which consists of a resiliently deformable bellows (9) and which is in communication with an upper valve (14) consisting of, in series: a stopper (16) for the channel (13) of the spout (8), which ensures that the end (32) is closed; a resiliently deformable diaphragm (15) enabling the stopper (16) to be opened; an auxiliary return member (17) suitable for the low pressures causing the closing of the stopper (16); and a sealed vessel (18), characterized in that the resiliently deformable diaphragm (15) is combined with the vessel (18) that said diaphragm seals, wherein the auxiliary return member (17) is arranged inside said vessel so as to be permanently linked to the diaphragm (15), and said vessel includes two levels (19, 20) that are resiliently deformable according to various characteristics.
Patent CA-2839959-A1 (CA)
Inventor: KARIM KHALID
IPC: C10G2/00
Filed: 2012-06-28
Abstract: The present invention relates to a method for preparing a catalyst composition comprising cobalt and molybdenum on a carbon support, characterized in that the cobalt- and molybdenum-source are dissolved in an organic solvent that is miscible with water. Moreover, a carbon supported cobalt molybdenum catalyst composition obtainable by said method and a process for producing alcohols from syngas using said carbon supported cobalt molybdenum catalyst composition is provided.
Patent CA-2842164-A1 (CA)
Inventor: JOSECK ERIC D
IPC: C10G65/12
Filed: 2012-07-12
Abstract: Methods are provided for producing multiple lubricating oil basestocks from a feedstock. Prior to dewaxing, various fractions of the feedstock are exposed to hydrocracking conditions of different severity to produce a higher overall yield of basestocks. The hydrocracking conditions of different severity can represent exposing fractions of a feedstock to different processing conditions, exposing fractions of a feedstock to different amounts of hydrocracking catalyst, or a combination thereof.
Patent CA-2844618-A1 (CA)
Title: Rupture panel
Inventor: WILSON ALAN
IPC: B65D25/00
Filed: 2011-08-09
Abstract: A rupture panel of three layers employs a lower layer (e.g., foam) that is adhesive, a middle layer (e.g., metallic) and a hold down layer. The middle layer has a weakened portion (scoring, openings, for example) that defines the panel burst pressure. A part of the lower layer does not connect to the middle layer. That part that does not connect to the middle layer adheres to the hold down layer. The hold down layer can be in the form of a ring with an open center, the weakened portion of the middle layer occupying a position within the open center of the hold down layer.
Patent CA-2847197-A1 (CA)
Title: Treatment for dupuytren's disease
Inventor: NANCHAHAL JAGDEEP
IPC: A61P19/04
Filed: 2011-10-31
Abstract: Musculoskeletal fibroproliferative disorders, such as Dupuytren's disease may be treated by administering locally a TNF-a antagonist. TNF-a antagonists find particular utility in inhibiting the progression of early disease state Dupuytren's disease and other musculoskeletal fibroproliferative disorders and, in combination with extracellular matrix degradation agents (such ascollagenase or matrix metalloproteinase I), treating advanced disease state Dupuytren's disease and, in particular inhibiting recurrence.
Patent CA-2847643-A1 (CA)
Inventor: DWYER CLIFFORD J
IPC: A61L27/14
Filed: 2007-02-15
Abstract: The present invention discloses a composite yarn comprising at least one wear-resistant polymeric fiber and at least one flexible polymeric fiber. The present invention also discloses a co-extruded filament comprising a polymeric inner core and a polymeric outer sheath. The polymeric inner core comprises a flexible polymeric material and the polymeric outer sheath comprises a wear-resistant polymeric material. The composite yarn and the co-extruded filament synergistically combine durability and flexibility, and thereby are particularly useful for the construction of graft materials. The present invention further discloses a reinforced fiber graft comprising wear-resistant beads and weaves of flexible polymeric fibers. In another aspect, the present invention discloses a process for assembling a graft device without suture knots by using the inventive co-extruded filament.
Patent CA-2847907-A1 (CA)
Title: Nanoparticle tumour vaccines
Inventor: RADEMACHER THOMAS
IPC: A61P35/00
Filed: 2012-09-07
Abstract: The present invention provides a vaccine for the prophylactic or therapeutic treatment of a tumour in a mammalian subject, as well as methods of using the vaccine, including in treatment of tumours and in generating a CTL response. The vaccine comprises a plurality of nanoparticles and a pharmaceutically acceptable carrier, salt or diluent. The nanoparticles comprise a core comprising a metal and/or a semiconductor atom; and a corona comprising a plurality of ligands covalently linked to the core, wherein at least a first ligand of said plurality comprises a carbohydrate moiety that iscovalently linked to the core via a first linker, and wherein at least a second ligand of said plurality comprises an epitopic peptide that is covalently linked to the core via a second linker, said second linker comprising a peptide portion and a non-peptide portion, wherein said peptide portion comprises the sequence X1X2Z1, wherein: X1 is an amino acid selected from A and G; X2 is an amino acid selected from A and G; and Z1 is an amino acid selected from Y and F, and wherein said epitopic peptide forms at least a portion of or is derived from a Tumour-Associated Antigen (TAA).
Patent CA-2848617-A1 (CA)
Inventor: BARFORD RICK
IPC: C10L5/36
Filed: 2012-09-25
Abstract: A firelighter comprising a solidified emulsion of a liquid hydrocarbon encapsulated in polymerised aqueous resin, wherein the liquid hydrocarbon is present in an amount of 30 to 75% by weight of the firelighter, and wherein the firelighter also contains starch.
Patent CA-2848786-A1 (CA)
Inventor: CARCELLER GONZALEZ ELENA
IPC: C07D265/16
Filed: 2012-09-14
Abstract: The present invention belongs to the field of EP1 receptor ligands. More specifically it refers to compounds of general formula (I) having great affinity and selectivity for the EP1 receptor. The invention also refers to the process for their preparation, to their use as medicament for the treatment and/or prophylaxis of diseases or disorders mediated by the EP1 receptor as well as to pharmaceutical compositions comprising them.
Patent CA-2850765-A1 (CA)
Title: Anionic displacer molecules for hydrophobic displacement chromatography
Inventor: HAYMORE BARRY L
IPC: B01D15/42
Filed: 2012-10-03
Abstract: A process for separating organic compounds from a mixture by reverse- phase displacement chromatography, including providing a hydrophobic stationary phase; applying to the hydrophobic stationary phase a mixture comprising organic compounds to be separated; displacing the organic compounds from the hydrophobic stationary phase by applying thereto an aqueous composition comprising a non-surface active hydrophobic anionic displacer molecule and about 10 wt% or less of an organic solvent; and collecting a plurality of fractions eluted from the hydrophobic stationary phase containing the separated organic compounds; in which the non-surface active hydrophobic anionic displacer molecule comprises a hydrophobic anion and a counterion, CI, having the general formula A or B, as defined in the disclosure: [CM] [Cl]d [CM-R*-CM'l [Cl]d A B.
Patent CA-2851804-A1 (CA)
Inventor: SCHEFFLER TOWNER BENNETT
IPC: G01N33/497
Filed: 2012-10-12
Abstract: A method of testing a system (10), which has at least one electro- chemical sensor (40) for detecting an analyte gas within a housing (20) of the system (10), and the housing (20) has an inlet (22), in- cludes exhaling in the vicinity of the inlet (22) of the housing (20) of the system (10) and measuring a response to exhaled breath to test one or more transport paths of the system. Measuring the response to exhaled breath may, for example, include measuring the response of a sensor (40) within the housing (20) of the system that is responsive to the presence of exhaled breath. The sensor responsive to the pres- ence of exhaled breath may, for example, include an electrochemi- cally active electrode responsive to a gas within exhaled breath. The electrochemically active electrode may, for example, be responsive to carbon dioxide or to oxygen.
Patent CA-2854424-A1 (CA)
Title: Substituted pyrazolyl-based carboxamide and urea derivatives bearing a phenyl moiety substituted with an so2-containing group as vanilloid receptor ligands
Inventor: FRANK-FOLTYN ROBERT
IPC: C07D231/12
Filed: 2012-11-08
Abstract: The invention relates to substituted pyrazolyl-based carboxamide and urea derivatives bearing a phenyl moiety substituted with a S02-containing group as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
Patent CA-2856283-A1 (CA)
Title: Transcutaneous power transmission utilizing non-planar resonators
Inventor: STARK JOSEPH
IPC: A61M60/873
Filed: 2012-11-16
Abstract: A system for omni-orientational wireless energy transfer is described. A transmitter unit has a transmitter resonator with a coil that is configured to be coupled to a power supply to wirelessly transmit power to a receiver unit. A receiver unit has a receiver resonator with a coil coupled to a device load. At least one of the resonators is a non-planar resonator that spans a non-degenerate two-dimensional surface having at least one concave portion.
Patent CA-2856595-A1 (CA)
Title: Process for obtaining low molecular weight lignin (lml)
Inventor: TERS THOMAS
IPC: C07G1/00
Filed: 2012-11-26
Abstract: Process for obtaining resin or synthetic material using lignocellulosic material by treating lignocellulosic material with an aqueous extraction solution with a content of a C1-4-alcohol of 70% v/v to 95% v/v at a pH of 12 to 14, where a first aqueous solution of low molecular weight lignin (LML) is obtained which is converted to resin or synthetic material; and a process for obtaining LML and a process for concentrating LML where the first aqueous solution of LML is used for treating further lignocellulosic material to obtain aqueous solutions in which the LML is enriched compared with the first aqueous solution.
Patent CA-2857210-A1 (CA)
Title: Promoter derived from human gene
Inventor: MURAKAMI KENJI
IPC: C12P21/02
Filed: 2012-11-27
Abstract: The invention relates to transformed mammalian host cells in which the foreign protein secretion capacity has been enhanced by using a foreign gene expression vector having a promoter derived from a human gene, and to a method for producing a foreign protein using the cells. Provided is a step for accelerating the production of a foreign protein that serves as a proteinaceous drug in cultured mammalian cells or other such host cells. Provided is a promoter derived from a human gene having stronger promoter activity than a cytomegalovirus (CMV) promoter in cultured mammalian cells or other such host cells.
Patent CA-2857417-A1 (CA)
Inventor: LAVALAYE JORN
IPC: C09D7/65
Filed: 2013-03-14
Abstract: The invention relates to flake-form effect pigment- and solvent-containing pigment pastes. The invention further relates to the use of the flake-form effect pigment- and solvent-containing pigment pastes in order to produce effect-producing solvent-containing coating materials. The invention further relates to a method for producing effect-producing solvent-containing coating materials.
Patent CA-2859518-A1 (CA)
Inventor: SADLER BRENDA
IPC: E02D29/14
Filed: 2014-08-15
Abstract: Disclosed herein are catch basin grate covers comprising a frame; a grate; a heating element in thermal communication with the grate cover; and a power source in electric communication with the heating element. Also disclosed are catch basin grate covers comprising a frame; a grate; means for heating the grate cover; and means for supplying power to the means for heating. Also disclosed are methods of preventing the clogging of a catch basin grate cover due to ice, the method comprising applying electricity to the heating element of the above grate cover, whereby the resulting heat from the heat element causes the ice to thaw, thereby unclogging the catch basin grate cover.
Patent CA-2861099-A1 (CA)
Title: Laundry care compositions comprising thiophene azo carboxylate dyes
Inventor: TORRES EDUARDO
IPC: C11D3/40
Filed: 2012-09-24
Abstract: This application relates to laundry care compositions comprising thiophene azo carboxylate fabric shading dyes and methods of treating a textile comprising such laundry care compositions.
Patent CA-2862824-A1 (CA)
Title: Multiplexed chromatography-immunoassay method for the characterization of circulating immune complexes
Inventor: DAHL UWE
IPC: G01N33/94
Filed: 2013-03-07
Abstract: Thus, herein is reported a method for analyzing/characterizing circulating immune complexes (CICs) formed in vivo comprising a size-exclusion chromatography of a sample obtained from a mammal to which the drug had been administered at least once for determining the weight/size of the immune complexes, optionally a second non-SEC chromatography, and at least one immunoassay, whereby the immune complex is characterized by the correlation of the immune complex size and the immunoassay result/read-out. Also reported herein is the use of a method as reported herein for determining a correlation to altered pharmacokinetics, for determining loss or reduction of efficacy, for determining neutralization of natural counterparts of the drug, for determining immune and hypersensitivity reactions, including serum sickness/type III hypersensitivity reaction/immune complexmediated disease.
Patent CA-2862985-A1 (CA)
Inventor: ARSENAULT JAMES
IPC: A41D13/05
Filed: 2012-01-27
Abstract: A back support system that comprises a belt portion being configured to provide back and abdominal support encircling a wearer's waist, a compression pants portion and a hot or cold pack providing therapy to a wearer's lumbosacral region. The belt portion has a left and right portions and a rear portion that extends upwardly from a cutout of the rear portion of the compression pants and is attached fixedly thereto. The rear portion of the belt portion has a pack support structure for receiving a hot or cold pack so as to maintain hot or cold therapy on the wearer's back. Slots in the belt portion may accommodate vertically extending inserts of rigid plastic or spiral metallic to reinforce the belt portion over the lumbosacral region of the wearer. A front core support structure provides abdominal support in combination with the back support that supports the entire core of the wearer's body. The garment can be changed to an immobilizing brace device by inserting optional rigid inserts.
Patent CA-2864210-A1 (CA)
Title: Configuration de soupape
Inventor: HJELMBERG ANDERS ERIK
IPC: B01D46/00
Filed: 2013-01-31
Abstract: L'invention porte sur une configuration de soupape. Elle a pour objet une configuration de soupape de filtre en tissu (9) apte à appliquer des impulsions de gaz comprimé pour nettoyer des sacs filtrants en tissu (6) dans un filtre en tissu (1). La configuration de soupape (9) comprend un plongeur (12) mobile par rapport à un bord (15) d'une première extrémité (16) d'un tube à impulsions (13). Lorsque la configuration de soupape (9) est fermée, le plongeur (12) bute contre le bord (15) de la première extrémité (16) du tube à impulsions (13), bloquant ainsi le flux de gaz comprimé dans l'intérieur (13a) du tube à impulsions (13). Une partie d'étanchéité (19) faite d'un matériau d'étanchéité est disposée au niveau du plongeur (12) et/ou du bord (15) de la première extrémité (16) du tube à impulsions (13).
Patent CA-2865874-A1 (CA)
Title: Circadian rhythm-improving agent
Inventor: OOISHI KATSUTAKA
IPC: A23L2/52
Filed: 2013-02-08
Abstract: The present invention provides a circadian rhythm-improving agent containing lactic acid bacteria or a processed product thereof as an active ingredient.
Patent CA-2866541-A1 (CA)
Inventor: GROESCHEL KERRY D
IPC: G01F1/66
Filed: 2013-05-02
Abstract: La présente invention porte sur un système et sur un procédé de mesure de débit à ultrasons. Selon un mode de réalisation, un système de mesure de débit à ultrasons comprend une pluralité de débitmètres à ultrasons. Chacun des débitmètres à ultrasons comprend un processeur de débit. Ledit processeur est configuré pour maintenir une pluralité de plateaux de vitesse, chacun des plateaux correspondant à une plage de vitesse de débit pour les débitmètres. Le processeur de débit est également configuré pour maintenir, dans chacun des plateaux, une valeur indicatrice d'une vitesse moyenne antérieure de débit de fluide à travers l'un donné des débitmètres associé à l'un donné des plateaux. Le processeur de débit est en outre configuré pour déterminer, en réponse à l'un des débitmètres défaillant, une vitesse d'écoulement de fluide moyenne estimée à travers le système en fonction des valeurs maintenues dans les plateaux.
Patent CA-2868288-A1 (CA)
Title: Antimicrobial compositions comprising pediocin, lactic acid and citric acid and uses thereof
Inventor: FLISS ISMAIL
IPC: A01N63/20
Filed: 2013-04-15
Abstract: The present invention relates to an antimicrobial composition having activity against Gram-positive and Gram-negative bacteria. The composition is a) a composition comprising at least two organic acids selected from the group consisting of lactic acid, acetic acid, benzoic acid and citric acid; b) a composition comprising at least two bacteriocin selected from the group consisting of pediocin, Nisin and reuterin; c) a composition comprising pediocin and at least two organic acids selected from the group consisting of lactic acid, acetic acid, benzoic acid and citric acid; or d) a composition comprising reuterin and at least one organic acid selected from the group consisting of lactic acid, acetic acid, benzoic acid and citric acid. The present invention also relates to the use of said compositions for sanitizing and/or disinfecting surfaces and method thereof.
Patent CA-2868742-A1 (CA)
Inventor: MANWARING PRESTON
IPC: A61B18/10
Filed: 2012-04-07
Abstract: An impedance matching circuit may be used to adjust for manufacturing and design tolerances in a surgical instrument. The matching circuit may match the load of a thermal element with the impedance of a power source used to deliver electrical energy to the surgical instrument. The matching circuit may include capacitors, inductors, coaxial cables, varactors, transformers, resistors, and/or combinations thereof. The matching circuit may also comprise a circuit board or flex board layers which may be modified to adjust the impedance of the load.